367 filings
Page 3 of 19
CORRESP
bmn11lrhqx4z
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
orllo52
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
ljn2qxo tk970s4dt
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
z4hb7hknv6
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
eayg4hqu7ql2z
24 Oct 23
Correspondence with SEC
12:00am
CORRESP
gl23yof dhdfcpx
24 Oct 23
Correspondence with SEC
12:00am
FWP
klkgjclm
5 Oct 23
Free writing prospectus
5:05pm
FWP
ge68flosch tuhr
3 Oct 23
Free writing prospectus
5:47pm
8-K
0hpeugt
28 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
8-K
3su syd4q
27 Sep 23
Other Events
4:03pm
UPLOAD
o8ymd161631bwitf
21 Sep 23
Letter from SEC
12:00am
SC 13D/A
35xr0tbtb qp3
18 Sep 23
AVENUE THERAPEUTICS / Fortress Biotech ownership change
5:08pm
4
env y181qfz742
12 Sep 23
AVENUE THERAPEUTICS / LINDSAY A MD ROSENWALD ownership change
9:03am
4
4u2 1ti9juxicwq8uoh
12 Sep 23
Change in insider ownership
9:02am
8-K
2rfswlxk
8 Sep 23
Entry into a Material Definitive Agreement
4:15pm
8-K
c6qovcre227hm
10 Aug 23
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:20pm